Ankara-based Turkish biotechnology company Burgeon Biyoteknoloji and Paris-headquartered Laboratoires VIVACY entered into a strategic partnership to accelerate the development and global rollout of advanced regenerative skin solutions. The collaboration merges two cutting-edge technological platforms with a shared goal of delivering high-performance, science-driven aesthetic innovations that address the evolving needs of healthcare professionals and patients worldwide.
Founded in 2017, Burgeon Biyoteknoloji specializes in biostimulation technologies and has quickly expanded its global presence, exporting products to more than 45 countries across Latin America, Asia-Pacific, the Middle East, and Europe. The company's commitment to R&D has positioned it as a dynamic player in skin regeneration.
Laboratoires VIVACY, recognized as one of the pioneers in aesthetic medicine, brings extensive international experience and innovation capacity to the partnership, backed by 15 patent families. Operating in over 85 countries, VIVACY has established subsidiaries in Switzerland, the UK, Canada, Poland, Spain, Italy, and the Benelux region, employing more than 300 professionals worldwide.
The collaboration is centered around NOVUMA, Burgeon's novel calcium hydroxyapatite-based biostimulator, which has gained significant attention for its regenerative capabilities. Commenting on the agreement, Laboratoires VIVACY President and CEO Bertrand Frohly noted, “NOVUMA presents a strategic opportunity for VIVACY to enter the rapidly growing biostimulator market. Our aim is to equip our specialist partners with the most advanced technologies available to safely and effectively meet patients' expectations for improved appearance and skin quality."
Burgeon Biyoteknoloji Founder and Managing Partner Levent Mete Özgürbüz expressed enthusiasm about the partnership, stating, “We are thrilled to embark on this globally significant collaboration. This agreement reflects the value of our innovative technologies and our shared commitment to pioneering new solutions that will set tomorrow's standards. Together with VIVACY, we look forward to developing cutting-edge treatments and achieving a global impact."
The partnership is expected to reinforce both companies' positions as leaders in regenerative aesthetics, enabling them to deliver integrated solutions that combine scientific rigor, safety, and effectiveness, while expanding their presence in key global markets.